BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15482339)

  • 1. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
    Tsuboi Y; Ichida T; Sugitani S; Genda T; Inayoshi J; Takamura M; Matsuda Y; Nomoto M; Aoyagi Y
    Liver Int; 2004 Oct; 24(5):432-6. PubMed ID: 15482339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.
    Ito Y; Sasaki Y; Horimoto M; Wada S; Tanaka Y; Kasahara A; Ueki T; Hirano T; Yamamoto H; Fujimoto J; Okamoto E; Hayashi N; Hori M
    Hepatology; 1998 Apr; 27(4):951-8. PubMed ID: 9537433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY; Wang HC; Feng DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
    Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
    Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
    Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
    Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
    Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
    Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
    Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx.
    Garavello W; Nicolini G; Aguzzi A; Maggioni D; Leone BE; Viganò P; Gaini RM; Tredici G
    Oncol Rep; 2006 Sep; 16(3):479-84. PubMed ID: 16865246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma.
    Osada S; Kanematsu M; Imai H; Goshima S; Sugiyama Y
    J Am Coll Surg; 2005 Sep; 201(3):405-11. PubMed ID: 16125074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased MAPK expression and activity in primary human hepatocellular carcinoma.
    Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
    Biochem Biophys Res Commun; 1997 Jul; 236(1):54-8. PubMed ID: 9223425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Malago M; Steveling K; Reis H; Cicinnati VR; Schmid KW; Baba HA
    J Hepatol; 2008 Jan; 48(1):83-90. PubMed ID: 17998146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.